Results 1 to 10 of about 419 (69)

The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study

Frontiers in Medicine, 2022
BackgroundThe convalescent plasma of patients who recover from coronavirus disease 2019 (COVID-19) contains high titers of neutralizing antibodies, which has potential effects on the viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-
Chun Pan, Hui Chen, Hui Chen, Jianfeng Xie, Yingzi Huang, Yi Yang, Bin Du, Haibo Qiu   +7 more
doaj   +1 more source

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)

Life, 2022
Background: Coronavirus disease 2019 is a global public health concern. As of December 2020, the therapeutic agents approved for coronavirus disease 2019 in Japan were limited to two drugs: remdesivir, an antiviral drug, granted a Special Approval for ...
Noriko Tomita, Sho Saito, Junko Terada-Hirashima, Ayako Mikami, Yukari Uemura, Satoshi Kutsuna, Hidetoshi Nomoto, Kyoko Fujisawa, Maki Nagashima, Mari Terada, Shinobu Ashida, Shinichiro Morioka, Masahiro Satake, Akira Hangaishi, Tomiteru Togano, Katsuyuki Shiratori, Yuki Takamatsu, Kenji Maeda, Norio Ohmagari, Wataru Sugiura, Hiroaki Mitsuya   +20 more
doaj   +1 more source

Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results

Einstein (São Paulo), 2021
The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-2, addressing the preliminary results of passive immunization through convalescent plasma.
Fernando Anselmo de Oliveira, Mariana Penteado Nucci, Gabriel Nery de Albuquerque Rego, Arielly da Hora Alves, Luciana Cavalheiro Marti, Leopoldo Penteado Nucci, Javier Bustamante Mamani, Lionel Fernel Gamarra   +7 more
doaj   +2 more sources

Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series

Journal of Medical Case Reports, 2021
Background Severe acute respiratory syndrome coronavirus 2, the cause of coronavirus disease 2019, has become a global pandemic. Currently, there is no definitive treatment for coronavirus disease 2019.
Theresia Monica Rahardjo, Elizabeth Yogipranata, Ardian Hediyanto Naswan, Fitri Rahayu Sari, Fajar Budiono, Hernawati Permatasari, C. H. R. Driantik Chuntari   +6 more
doaj   +1 more source

Outcome of Indoor Covid Cases with Moderate to Severe Disease; Convalescent Plasma Transfusion vs Conventional Therapy

Journal of Bahria University Medical and Dental College, 2022
Objectives: Global COVID-19 epidemic has been therapeutic challenge. Convalescent plasma is observed to improve clinical outcomes. This research aims to study whether convalescent plasma therapy reduces the mortality and duration of hospitalization in ...
Lubna Meraj , Muhammad Usman, Nadia Shams, Muhammad Umar, Sidra Tahir, Nasim Akhtar, Muhammad Khalid Mehmood Randhawa, Asif Majid, Ashar Alamgir   +8 more
doaj   +1 more source

Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis

Scientific Reports, 2023
Insight into the clinical potential of convalescent plasma in patients with coronavirus disease (COVID-19) is important given the severe clinical courses in unvaccinated and seronegative individuals.
Nora Mihalek, Dragana Radovanović, Otto Barak, Petar Čolović, Markus Huber, Gabor Erdoes   +5 more
doaj   +1 more source

COMPARISON OF MORTALITY BETWEEN THE COMBINATION OF STANDARD THERAPY AND CONVALESCENT PLASMA THERAPY AND STANDARD THERAPY ONLY IN COVID-19 PATIENTS : SYSTEMATIC REVIEW AND META-ANALYSIS

Journal of Community Medicine and Public Health Research, 2021
Coronavirus Disease-19 (COVID-19) is an infectious disease caused by a newly discovered type of coronavirus. Comprehensive management for COVID-19 patients includes infection control, hemodynamic stability maintenance, oxygenation monitoring, ventilation,
Felicia Klarin, Angelica Diana Vita, Cynthia Elvira Sari Siahaan, Salsabila Nabilah Rifdah, Ayu Rahmanita Putri, Indriasti Putri Kusuma, Subur Prayitno   +6 more
doaj   +1 more source

Neutrophil Lymphocyte Ratio (NLR) in COVID-19 Patients Receiving Convalescent Plasma Therapy

Indonesian Journal of Medical Laboratory Science and Technology, 2022
Recently, a new RNA virus from the Coronaviridae family was discovered, known as SARS-Cov-2. This virus causes pneumonia and inflammation in the body.
Desyani Ariza, Andi Maya Kesrianti, Tazya Anggraini Ruslan   +2 more
doaj   +1 more source

Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy

Frontiers in Immunology, 2021
Here, we described the case of a B cell-deficient patient after CD19 CAR-T cell therapy for refractory B cell Non-Hodgkin Lymphoma with protracted coronavirus disease 2019 (COVID-19).
Berislav Bošnjak, Ivan Odak, Christiane Ritter, Klaus Stahl, Theresa Graalmann, Theresa Graalmann, Lars Steinbrück, Rainer Blasczyk, Christine S. Falk, Christine S. Falk, Thomas F. Schulz, Thomas F. Schulz, Thomas F. Schulz, Hans Heinrich Wedemeyer, Hans Heinrich Wedemeyer, Hans Heinrich Wedemeyer, Markus Cornberg, Markus Cornberg, Markus Cornberg, Arnold Ganser, Reinhold Förster, Reinhold Förster, Christian Koenecke, Christian Koenecke, Christian Koenecke   +24 more
doaj   +1 more source

HISTORY OF PLASMA THERAPY: A CURRENTLY USED TREATMENT OPTION FOR COVID-19

İstanbul Tıp Fakültesi Dergisi, 2021
The current pandemic provides the most incredible opportunity to develop convalescent plasma therapy into an effective treatment modality for the coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2 ...
Esra Bilir, Emine Elif Vatanoğlu Lutz, Ayşe Arzu Akalın   +2 more
doaj   +1 more source